{
    "clinical_study": {
        "@rank": "122745", 
        "acronym": "VITAPOP", 
        "arm_group": [
            {
                "arm_group_label": "Ferinject", 
                "arm_group_type": "Active Comparator", 
                "description": "Once an infusion of Ferinject 1000 mg, 1 day after surgery"
            }, 
            {
                "arm_group_label": "Ferrous fumarate", 
                "arm_group_type": "Active Comparator", 
                "description": "2 times  a day 200 mg ferrous fumarate, starting 24-48 hours after surgery"
            }, 
            {
                "arm_group_label": "Placebo infusion and tablets", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Patient will get a once a placebo infusion (250 ml NaCl), one day after surgery, and 60 placebo tablets for 30 days (2 tablets a day), starting 24-48 hours after surgery"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether oral or intravenous iron is effective in\n      the treatment of anaemia (iron-poor blood) after gynaecologic surgery."
        }, 
        "brief_title": "The Use of Iron Therapy for Patients With Anemia After Surgery", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Postoperative Anaemia", 
        "condition_browse": {
            "mesh_term": "Anemia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Gynecological surgery\n\n          -  Hb 5-7 mmol/L\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n          -  Oncological operations\n\n          -  Infections (PID)\n\n          -  Diagnostic procedures: level 1 laparoscopies (diagnostic, sterilization,  tubal\n             testing; Hysteroscopies\n\n          -  Smaller therapeutic procedures: large loop excision of transformation zone  (LLETZ),\n             Conization,\n\n          -  Small vulvar / vaginal operations such as (cysts,  labia correction)\n\n          -  Endometrial ablation\n\n          -  Legal incapacity\n\n          -  The patient has used pre-operatively an iron preparation and / or blood transfusion\n             or during the surgery\n\n          -  Hematologic disorders\n\n          -  Erythropoiesis-stimulating agents &lt; 3months ago\n\n          -  Myelosuppressive therapy in history\n\n          -  Hepatitis\n\n          -  HIV\n\n          -  Alcohol abuses\n\n          -  Not understanding Dutch\n\n          -  Allergic reaction to iron therapy in past"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01975272", 
            "org_study_id": "METC 12-2-018"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ferinject", 
                "intervention_name": "Ferinject", 
                "intervention_type": "Drug", 
                "other_name": [
                    "intravenous iron", 
                    "ferric carboxymaltose"
                ]
            }, 
            {
                "arm_group_label": "Ferrous fumarate", 
                "intervention_name": "Ferrous fumarate", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Oral iron", 
                    "Iron (II) fumarate"
                ]
            }, 
            {
                "arm_group_label": [
                    "Ferinject", 
                    "Placebo infusion and tablets"
                ], 
                "intervention_name": "Placebo for ferrous fumarate", 
                "intervention_type": "Drug", 
                "other_name": "Placebo tablets"
            }, 
            {
                "arm_group_label": [
                    "Ferrous fumarate", 
                    "Placebo infusion and tablets"
                ], 
                "intervention_name": "Placebo for ferinject", 
                "intervention_type": "Drug", 
                "other_name": "NaCl"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ferrous fumarate", 
                "Iron"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "postoperative", 
            "anemia", 
            "gynaecologic", 
            "surgery"
        ], 
        "lastchanged_date": "October 28, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Maastricht", 
                        "country": "Netherlands", 
                        "state": "Limburg", 
                        "zip": "6202 AZ"
                    }, 
                    "name": "Maastricht University Medical Centre"
                }, 
                "investigator": {
                    "last_name": "Roy RFPM Kruitwagen, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sittard", 
                        "country": "Netherlands", 
                        "state": "Limburg", 
                        "zip": "6162 BG"
                    }, 
                    "name": "Orbis Medical Centre"
                }, 
                "investigator": {
                    "last_name": "Celine CMJG Lardenoije, Drs.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_arms": "3", 
        "official_title": "The Value of Iron Treatment for Postoperative Patients With Anemia: a Randomized Double Blind Controlled Trial", 
        "overall_contact": {
            "email": "c.lardenoije@gmail.com", 
            "last_name": "Celine CMJG Lardenoije, Drs.", 
            "phone": "00316-17028468"
        }, 
        "overall_contact_backup": {
            "email": "r.kruitwagen@mumc.nl", 
            "last_name": "Roy RFPM Kruitwagen, Prof. Dr.", 
            "phone": "0031-433874764"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Netherlands: Medical Ethics Review Committee (METC)", 
                "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Hemoglobin", 
            "safety_issue": "No", 
            "time_frame": "3 weeks postoperative"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01975272"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Quality of life will be determined by using the next questionnaires: European Health Related Quality of Life  (euro HRQol) and Multidimensional Fatigue Inventory (MFI)", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "1,3 and 6 weeks postoperative"
            }, 
            {
                "description": "In the questionnaire one has to fill out if there are any side effects like Nausea; Stomach ache; constipation; Diarrhea; Skin rash; Headache; Dizziness; Other....", 
                "measure": "Side effects of medication", 
                "safety_issue": "No", 
                "time_frame": "1,3 and 6 weeks postoperative"
            }, 
            {
                "measure": "Predictive value of other parameters C reactive protein (CRP) ,transferrin, ferritin, hepcidin", 
                "safety_issue": "No", 
                "time_frame": "3 and 6 weeks postoperative"
            }
        ], 
        "source": "Maastricht University Medical Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Vifor Pharma", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Maastricht University Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}